Frankfurt/Main
ab sofort
Do you want to contribute to cutting-edge research in cell and gene therapy? Then this is the place for you. Our focus is on improving in vivo gene therapy and investigating epigenetic modifiers and leukaemic mutations. If you are looking for a challenging role in an innovative, interdisciplinary team, we look forward to hearing from you!

• The targeted modulation of epigenetic modifiers to optimize in vivo gene therapies, particularly in developing new approaches for monogenic blood disorders.
• Analyzing the effects of known leukemic mutations on the expression of relevant transcripts, both in absolute and relative terms